March 7, 2024 · Form 4 insider transaction
Freitag Gregory Gene sold 25,000 shares of AxoGen, Inc. at $9.00 per share, a transaction worth $225.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $8.95 to $9.00 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.